Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AQCLAIM Study: Qsymia Cardiovascular Morbidity and Mortality in Subjects with Documented Cardiovascular Disease
2012-003946-34Phase 3Unknown
- Sponsor
- VIVUS
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cardiac morbidity, Overweight and obesity comparing Qsymia arm with Placebo arm (2 arms). Status: unknown.
02
Drugs
phentermine + topiramate
03
Conditions
cardiac morbidityOverweightobesity
Beyond the preview
Go deeper on 2012-003946-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003946-34.